Droplets packed with hemoglobin may briefly form tiny clusters inside red blood cells that ultimately deform their shape, and cause…
José Lopes, PhD
José holds a PhD in neuroscience from the University of Porto, Portugal. After postdocs at Weill Connell Medicine and Western University, where he studied the processes driving hypertension and Alzheimer’s disease, he moved on in 2016 to a career in science writing and communication. José is the author of several peer-reviewed papers and a book chapter and has presented his research in numerous international meetings.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by José Lopes, PhD
Insufficient levels of selenium in patients with sickle cell disease (SCD) are associated with red blood cell destruction, or…
Children and adolescents with sickle cell anemia (SCA) showed low adherence to treatment with hydroxyurea, according to a…
The U.S. opioid epidemic is not linked to higher in-hospital mortality in patients with sickle cell disease (SCD), according…
The blood level of a small protein called IP-10 could be a way to determine inflammation in pregnant women with…
Under a new treatment protocol, seven adults with sickle cell anemia were treated — and reportedly cured — using…
In-person education of caregivers increases their knowledge of sickle cell trait (SCT), according to researchers. But new strategies are needed…
A gene editing technology called CRISPR/Cas9 repaired 20 to 40 percent of stem and progenitor cells obtained from sickle cell…
An upcoming Phase 1 clinical trial was recently awarded $5.74 million to evaluate an innovative blood stem cell transplant…
Voxelotor, a potential treatment for sickle cell anemia (SCA), has been given breakthrough therapy designation (BTD), Global Blood…